| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥112.4B | ¥108.4B | +3.8% |
| Operating Income | ¥8.0B | ¥6.9B | +16.8% |
| Ordinary Income | ¥8.4B | ¥7.4B | +12.5% |
| Net Income | ¥5.3B | ¥4.6B | +14.9% |
| ROE | 4.7% | 4.2% | - |
FY2025 Q3 cumulative results show revenue of ¥112.4B (+3.8% YoY), Operating Income of ¥8.0B (+16.8% YoY), Ordinary Income of ¥8.4B (+12.5% YoY), and Net Income of ¥5.3B (+14.9% YoY). The company achieved revenue growth with accelerated profit expansion, demonstrating improved operating leverage. Operating margin improved to 7.1% from 6.4% in the prior year period, while net profit margin reached 4.7% compared to 4.2% YoY. Basic EPS increased 15.0% to ¥103.69 from ¥90.20, reflecting bottom-line growth outpacing revenue gains.
Revenue increased 3.8% to ¥112.4B, driven by growth across both reporting segments. The Packaging segment, which represents the core business at 89.1% of total revenue, grew 3.7% to ¥100.1B with segment profit increasing 16.9% to ¥11.1B and margin expanding to 11.1%. The Precision Coating segment revenue rose 14.2% to ¥9.7B with segment profit of ¥3.1B at a 32.5% margin, demonstrating strong profitability in this higher-margin business. The Other segment revenue declined 20.8% to ¥2.6B with segment loss of ¥0.04B compared to profit of ¥0.25B in the prior period, primarily due to contract and promotional goods business challenges.
Operating profit growth of 16.8% significantly outpaced revenue growth, resulting from improved gross margin to 21.5% and controlled SG&A expenses at 14.3% of revenue. The prior period included system-related impairment losses of ¥1.2B classified as extraordinary losses, related to core system reconstruction review and software write-downs. This non-recurring factor impacted the prior period's net income baseline, making the current period's 14.9% net income growth partially attributable to absence of such charges.
The gap between operating income of ¥8.0B and ordinary income of ¥8.4B reflects net non-operating income of approximately ¥0.4B, comprising dividend income of ¥0.6B and interest income of ¥0.1B, partially offset by interest expense of ¥0.4B. Ordinary income to net income declined from ¥8.4B to ¥5.3B due to tax expenses of approximately ¥2.1B, resulting in an effective tax rate around 28%. Extraordinary items in the current period were minimal with net extraordinary loss of ¥0.9B (gain on asset sales ¥0.1B offset by impairment losses ¥1.2B), representing 16.4% of profit before tax.
This represents a revenue up, profit up pattern with operating leverage driving accelerated profit growth, though elevated extraordinary items warrant monitoring for earnings quality.
The Packaging segment is the core business representing 89.1% of total revenue with ¥100.1B in sales and operating income of ¥11.1B at an 11.1% margin. This segment grew revenue 3.7% YoY with operating profit expanding 16.9%, demonstrating strong operational efficiency gains. The Precision Coating segment contributed ¥9.7B in revenue with ¥3.1B operating income at a notably higher 32.5% margin, growing revenue 14.2% YoY with profit up 6.9%. The significantly higher profitability in Precision Coating versus Packaging (32.5% vs 11.1% margin) indicates this smaller segment possesses pricing power and differentiated capabilities. The Other segment generated ¥2.6B revenue but reported an operating loss of ¥0.04B, deteriorating from ¥0.25B profit in the prior period, as food, cosmetics, and pharmaceutical processing contracts alongside promotional goods sales faced headwinds. Corporate expenses not allocated to segments totaled ¥6.2B, increasing from ¥5.8B YoY, which partially offset segment-level profit improvements.
[Profitability] ROE of 4.7% remains below the manufacturing industry median of 5.8%, while operating margin of 7.1% trails the industry median of 8.9%, indicating room for improvement relative to peers. Net profit margin of 4.7% compares to industry median of 6.5%, reflecting lower profitability conversion. ROIC of 4.8% significantly underperforms the industry median of 6.0%, suggesting suboptimal capital allocation efficiency. [Cash Quality] Cash and deposits of ¥20.1B declined 25.2% from ¥26.8B YoY, covering short-term debt 5.74 times but representing a concerning liquidity reduction. Receivables turnover deteriorated to 94 days, elevated versus the industry median of 85 days, indicating collection efficiency challenges. [Investment Efficiency] Asset turnover of 0.540 aligns with the industry median of 0.56, showing comparable asset utilization. Inventory turnover of 45 days compares favorably to the industry median of 112 days, reflecting efficient inventory management. [Financial Health] Equity ratio of 53.9% falls below the industry median of 63.8%, indicating relatively higher leverage within sector norms. Current ratio of 136.9% substantially trails the industry median of 287%, suggesting tighter working capital management. Debt-to-equity ratio of 0.85 and interest coverage of 18.78 times demonstrate adequate debt servicing capacity with net debt to EBITDA estimated around 1.5, remaining within prudent ranges.
Cash and deposits decreased ¥6.8B YoY to ¥20.1B, representing a 25.2% decline that warrants attention for liquidity management. Working capital movements show accounts receivable at ¥28.9B and notes receivable at ¥21.4B, while notes payable reached ¥25.9B, indicating ongoing trade credit utilization. The substantial cash decline alongside flat to growing receivables suggests operating cash generation may be constrained by collection timing, with receivables days of 94 exceeding industry norms. Inventory remained stable at ¥5.4B with efficient turnover of 45 days. Current assets of ¥86.1B against current liabilities of ¥62.9B maintain a current ratio of 136.9%, though cash coverage has diminished. Non-current assets increased to ¥121.9B from ¥118.5B, likely reflecting continued capital investment partially offset by depreciation. The equity position strengthened to ¥112.2B from ¥109.8B, absorbing profit retention net of distributions. Short-term debt coverage by cash stands at 5.74 times, down from higher levels, indicating adequate but declining liquidity buffer.
Ordinary income of ¥8.4B versus operating income of ¥8.0B reflects net non-operating contribution of approximately ¥0.4B, comprising primarily dividend income of ¥0.6B partially offset by interest expense of ¥0.4B. Non-operating income represents approximately 1.1% of revenue, consisting mainly of financial income with minimal foreign exchange impacts disclosed. The gap between ordinary income and net income of ¥3.1B is largely attributable to tax expenses of approximately ¥2.1B plus extraordinary losses of ¥0.9B. Extraordinary items totaling ¥0.9B net loss (¥0.1B gain on asset sales less ¥1.2B impairment losses, primarily system-related) represent 16.4% of profit before tax and 24.7% of net income, indicating material impact from non-recurring factors. While the prior period contained even larger impairment charges of ¥1.2B related to core system reconstruction, the persistence of system-related charges in the current period raises questions about recurring vs. non-recurring classification. Without operating cash flow data, verification of earnings quality through cash conversion cannot be performed, though the concerning 25.2% decline in cash position alongside profit growth suggests potential accruals or working capital deterioration affecting cash realization.
Full-year guidance projects revenue of ¥152.0B (+4.2% YoY), operating income of ¥9.0B (+1.0% YoY), and ordinary income of ¥9.1B (-2.1% YoY). Q3 cumulative progress rates stand at 73.9% for revenue, 89.1% for operating income, and 91.9% for ordinary income against full-year targets. Operating income progress of 89.1% substantially exceeds the standard 75% benchmark for Q3, indicating strong first nine-month performance and suggesting potential for upside to guidance or conservatism in Q4 assumptions. Revenue progress of 73.9% slightly trails the standard pace, implying Q4 revenue acceleration will be needed to meet targets. The divergence between strong operating income progress and weaker ordinary income guidance (-2.1% YoY decline expected) suggests anticipated deterioration in non-operating items or tax factors in Q4. Given current momentum with operating income already at 89% of full-year target, the ¥9.0B operating income forecast appears achievable to conservative unless significant Q4 headwinds materialize.
The company plans a semi-annual dividend of ¥5.0 for Q2 and year-end dividend of ¥17.5, totaling ¥22.5 per share. Based on forecast EPS of ¥127.15, the implied payout ratio would be approximately 17.7%. However, using the current nine-month actual EPS of ¥103.69 annualized suggests lower full-year EPS, which would result in a higher payout ratio approaching 27-30% range if ¥127.15 forecast is not achieved. At the forecasted EPS of ¥127.15, the 17.7% payout ratio remains conservative and sustainable. The absence of disclosed share buyback activity limits total shareholder return to dividend payments only. With net income of ¥5.3B for nine months, total annual dividends of approximately ¥1.1B (based on average shares outstanding of 5,033K) represent roughly 17-20% of current run-rate earnings, leaving substantial cash for reinvestment or balance sheet management.
Customer collection risk poses material concern as receivables days of 94 exceed the manufacturing industry median of 85 days by 11%, with the 25.2% cash decline indicating potential stress in converting sales to cash. If collection deterioration continues, working capital requirements could constrain operational flexibility and necessitate increased borrowing. Segment concentration risk in Packaging business at 89% of revenue creates vulnerability to demand shifts, raw material cost fluctuations, or competitive pricing pressures in this core lower-margin segment, as evidenced by 11.1% segment margin versus 32.5% in Precision Coating. Recurring extraordinary charges risk continues as system-related impairment of ¥1.2B in the current period follows prior period charges of ¥1.2B for core system reconstruction review, suggesting ongoing IT investment challenges that may recur and pressure profitability if digital transformation initiatives continue facing execution issues.
[Industry Position] (Reference - Proprietary Analysis)
Profitability metrics trail industry norms with ROE of 4.7% versus manufacturing sector median of 5.8%, operating margin of 7.1% versus median of 8.9%, and net profit margin of 4.7% versus median of 6.5%, positioning the company in the lower half of profitability rankings. ROIC of 4.8% versus sector median of 6.0% indicates below-average capital efficiency. Financial health shows equity ratio of 53.9% versus industry median of 63.8%, reflecting relatively higher leverage, while current ratio of 136.9% substantially trails the sector median of 287%, suggesting tighter liquidity management than peers. Operational efficiency demonstrates strength in inventory management with 45-day turnover versus industry median of 112 days, though receivables days of 94 exceed the median of 85 days, indicating collection challenges. Revenue growth of 3.8% YoY exceeds the industry median of 2.8%, showing above-average top-line momentum. Asset turnover of 0.540 aligns closely with the median of 0.56, indicating comparable asset utilization efficiency. The company's conservative leverage profile with financial leverage of 1.85 versus median of 1.53 combines with below-median profitability to constrain return metrics, suggesting opportunity to either improve operating margins or optimize capital structure to enhance shareholder returns.
(Industry: Manufacturing sector, Comparison: FY2025 Q3 period, Source: Proprietary analysis)
Operating leverage driving profit growth is the primary positive characteristic, with operating income growing 16.8% on revenue growth of only 3.8%, demonstrating scale benefits and cost management effectiveness that improved operating margin by 70 basis points to 7.1%. This earnings momentum positions the company favorably if top-line growth continues, as incremental margins appear strong. Capital efficiency improvement opportunity represents a structural challenge and potential upside catalyst, as ROE of 4.7% and ROIC of 4.8% substantially lag manufacturing sector medians of 5.8% and 6.0% respectively, indicating the company generates below-average returns on deployed capital. Persistent underperformance on these metrics suggests either operating margin expansion, asset turnover improvement, or capital reallocation could unlock significant value. Liquidity deterioration and collection challenges emerge as the most concerning trend from the earnings data, with cash declining 25.2% to ¥20.1B while receivables days stretched to 94 versus industry median of 85 days, suggesting working capital management pressures that could constrain financial flexibility if not addressed through collection process improvements.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.